CD44 and cancer: Moreover, OPN–CD44 interactions have been shown to activate downstream signaling pathways, such as phosphatidylinositol 3-kinase (PI3K)/Akt cascade63 and TIAM1–Rac1 signaling64, that are highly associated with cancer progression and metastasis via enhancing cell proliferation, survival, and mobility.